Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerBilling CodesQualitative or Semiquantitative ImmunoassaysCPT cpt-86702-hiv-2-antibody-immunoassay
    Ask Trek AI about this page

    CPT 86702: Immunoassay for HIV‑2 Antibodies in Serum

    Commercial payers pay $41 on average nationally for this procedure.

    CPT code 86702 describes a laboratory immunoassay performed by a lab analyst to detect antibodies to HIV‑2 in a patient’s serum, a diagnostic serology test typically performed in clinical laboratories or hospital lab settings as part of HIV evaluation or screening.

    For related coverage guidance, see recent payer policy updates: Allergen Subcutaneous Immunotherapy (SCIT), Allergy Testing, Including Selected Blood, Serum and Cellular Testing and Toxicity Testing Corporate Medical Policy, Allergy and Sensitivity Tests of Uncertain Efficacy.

    Customize your policy alerts

    Sign up for cpt 86702 policy alerts

    Get alerted when payer policies referencing 86702 are released or updated.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    National Reimbursement Benchmarks

    National commercial rates for CPT 86702 cluster around the BUCA average commercial rate of $40.9, with sizable variation across individual payers. Blue Cross Blue Shield shows the highest dispersion in the central spread (P75–P25 = $32.5), reflecting a wide middle 50% of contract rates; Cigna (P75–P25 = $11.4) and UnitedHealth Group (P75–P25 = $7.5) are notably tighter, indicating more consistency among contracted rates. Aetna’s spread (P75–P25 = $4.0) is the narrowest of the set, suggesting relatively low mid‑range variability.

    Absolute median and mean levels vary: Blue Cross Blue Shield has the highest median at $61.8 and mean at $62.3, while Aetna, Cigna, and UnitedHealth Group center closer to the low‑teens or below. BUCA’s mean of $40.9 sits between the low and high payers, representing an average commercial benchmark rather than an extreme. Range differences highlight where negotiation and contract diversity produce more variable payer outcomes.

    Table of contents

    Progress1 / 9

    Explore openpayer tools

    • Billing CodesCPT, HCPCS, DRG & more
    • Reimbursement RatesCommercial vs. Medicare rate reports
    • Facility ComparisonBeds, revenue & payer mix
    • ProvidersHospitals & facilities
    • PayersPlans & market footprint
    • Taxonomy CodesNUCC specialty codes
    • ModifiersCPT modifiers & usage
    • Prior AuthorizationPA policies by payer & drug
    • Timely FilingFiling deadlines by payer
    • Coverage CriteriaMedical necessity by payer
    • Payer ContactsClaims, PA & appeals contacts
    View all tools
    National Payer Mean Reimbursement Rates

    State Reimbursement Rates

    State: Alaska1 / 51

    Rate by payer

    Clinical & Coding Specifications

    Clinical Context

    A 32-year-old patient presents to a primary care clinic for routine sexually transmitted infection screening after a reported possible exposure. The clinician orders serologic testing for HIV, including an immunoassay specific to HIV‑2 antibodies. A venous blood sample is collected in the clinic phlebotomy area and sent to the clinical laboratory (Clinical Medical Laboratory taxonomy 291U00000X) for processing. The laboratory performs 86702 (antibody; HIV‑2) immunoassay. Results are reported in the electronic medical record to the ordering provider (family medicine 207Q00000X or internal medicine 207R00000X) and interpreted in context of prior testing: a negative HIV‑2 antibody result supports no detectable HIV‑2 seroconversion; a positive or reactive result prompts reflex confirmatory testing (for example, confirmatory antibody or supplemental testing) and public health reporting. Typical site of service is an outpatient primary care clinic or an independent clinical laboratory. Common clinical scenarios include: screening encounter for HIV (Z11.4), asymptomatic known HIV infection monitoring (Z21/B20 when relevant), investigation of inconclusive prior serology (R75), or evaluation after known exposure (Z20.6). The workflow: order placed by clinician → specimen collected → specimen accessioned in lab → immunoassay 86702 performed → result routed to ordering provider → reactive results trigger confirmatory testing and patient notification protocols.

    Related CPT Codes

    Related Modifiers

    5 rows

    ModifierDescriptionWhen to Use
    26Modifier 26 (Professional Component) identifies and bills only the professional portion of a split service — the physician’s interpretation, report, and medical judgment — when the technical…- Use CPT Modifier -26 when you are billing only the professional component (PC) of a split‑bill eligible service—i.e., you performed the physician interpretation, medical judgment and prepared a…
    59Modifier 59 indicates a distinct procedural service when two procedures that are not normally billed together are clinically and procedurally separate. The CPT definition (as reiterated by CMS)…- Use modifier -59 to report a distinct procedural service when documentation supports that the procedure reported is not normally billed together with another service on the same day because of a…
    90Modifier ‑90 (Reference/Outside Laboratory) indicates that a laboratory test was performed by an entity other than the treating or reporting provider. The American Medical Association defines…- Use CPT modifier -90 when a laboratory test is performed by an outside/reference laboratory (an entity other than the treating or reporting physician or qualified professional) and the claim needs…
    91Modifier 91 — “Repeat Clinical Diagnostic Laboratory Test” — is appended when the exact same CPT laboratory test is performed more than once for the same patient on the same day because serial,…- Use modifier 91 when the exact same CPT laboratory test is performed more than once on the same patient on the same date because serial or repeated testing is medically necessary to monitor…
    55Modifier –55 indicates the billing provider furnished only postoperative management for a procedure that has a global surgical period. According to AAPC, this modifier is appended to the same CPT…- Use modifier -55 when billing the same CPT surgical code that has a 10- or 90-day global period and you, as a provider other than the original surgeon, furnished ONLY postoperative management (no…

    Related Provider Taxonomies

    8 rows

    Taxonomy Code
    291U00000X
    207Q00000X
    207R00000X
    163WP2201X
    2081N0008X
    1223D0004X
    163WR0006X
    163WW0000X

    Related ICD-10-CM Codes

    25 rows

    ICD-10-CM CodeDescription
    A64Unspecified sexually transmitted disease
    B20Human immunodeficiency virus [HIV] disease
    B37.89Other sites of candidiasis
    B97.35Human immunodeficiency virus, type 2 [HIV 2] as the cause of diseases classified elsewhere
    D50.9Iron deficiency anemia, unspecified
    D70.9Neutropenia, unspecified
    F10.20Alcohol dependence, uncomplicated
    F11.20Opioid dependence, uncomplicated
    J02.9Acute pharyngitis, unspecified
    N39.0Urinary tract infection, site not specified

    Showing 1–10 of 25

    Related Payer Policy Updates

    Specialty: Allergy/Clinical Immunology1 / 3

    10 rows

    PolicyPayerEffective Date
    Allergen Subcutaneous Immunotherapy (SCIT)Providence Health Plan2026-11-01
    Allergy Testing, Including Selected Blood, Serum and Cellular Testing and Toxicity Testing Corporate Medical Policybcbsvermont2026-11-01
    Allergy and Sensitivity Tests of Uncertain Efficacyregence2026-10-01
    Allergy Testing and InjectionsUnitedHealthcare2026-10-01
    Allergy TestingProvidence Health Plan2026-10-01
    Diagnosis of Idiopathic Environmental IntoleranceOscar Health2026-10-01
    Allergen Testingblue cross blue shield - louisiana2026-09-15
    Allergen TestingBlue Cross Blue Shield - New Mexico2026-09-04
    Allergen Immunotherapymarylandphysicianscarempc2026-09-01
    ALLERGY TESTING / IMMUNOTHERAPYpriority_health_medicare2026-09-01

    Related Codes

    86803-QUALITATIVE-OR-SEMIQUANTITATIVE-IMMUNOASSAYS-HEPATITIS-C

    CPT 86803: Hepatitis C Antibody Immunoassay in Serum

    CPT-86000-FEBRILE-AGGLUTININS-SEROLOGIC-TEST

    CPT 86000: Febrile Agglutinins (Serologic Agglutination) Test

    CPT-86001-ALLERGEN-SPECIFIC-IGG-LABORATORY-TEST

    CPT 86001: Allergen-Specific IgG Assay, Technical Component

    CPT-86003-ALLERGEN-SPECIFIC-IGE-ASSAY-TECHNICAL

    CPT 86003: Allergen‑Specific IgE Assay Using Crude Allergen Extract

    CPT-86005-MULTI-ALLERGEN-IGE-SCREENING-QUALITATIVE

    CPT 86005: Multi-Allergen Allergen-Specific IgE Screening

    CPT-86008-ALLERGEN-COMPONENT-SPECIFIC-IGE-ASSAY

    CPT 86008: Allergen Component–Specific IgE Assay

    CPT-86015-ANTI-ACTIN-SMOOTH-MUSCLE-ANTIBODY-ASMA

    CPT 86015: Actin (Smooth Muscle) Antibody (ASMA) Immunoassay

    CPT-86021-LEUKOCYTE-ANTIBODY-IDENTIFICATION-LAB-TECHNICAL

    CPT 86021: Leukocyte Antibody Identification Laboratory Test

    CPT-86022-PLATELET-ANTIBODY-IDENTIFICATION-TECHNICAL-TEST

    CPT 86022: Platelet Antibody Detection and Identification

    CPT-86023-PLATELET-ASSOCIATED-IMMUNOGLOBULIN-DETECTION

    CPT 86023: Platelet-Associated Immunoglobulin Assay

    Showing 1–10 of 199

    • More pages

    Frequently Asked Questions

    References

    1. 1.CPT® Codes and Descriptions. AAPC. Retrieved Aug 11, 2026.Maintains the CPT code set's official descriptions and guidelines, licensed from the American Medical Association, used as the definitional source for CPT codes on this page.
    2. 2.HCPCS Quarterly Update. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's quarterly release of HCPCS Level II codes and short/long descriptors, the source for HCPCS code definitions and update history.
    3. 3.ICD-10-CM Full Code List. Centers for Medicare & Medicaid Services (CMS). Retrieved Aug 11, 2026.CMS's complete ICD-10-CM diagnosis code list, used to cross-reference diagnosis codes associated with this procedure or service.
    Published by

    Trek Health powers OpenPayer with a leading commercial payer intelligence platform, seamlessly converting fragmented payer data into actionable insights for provider organizations.

    Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

    CPT CodeDescriptionRelationship to This Procedure
    86701Antibody; HIV‑1Alternative single-agent antibody test for HIV‑1; may be ordered separately when HIV‑1 specific serology is required.

    86703 | Antibody; HIV‑1 and HIV‑2, single result | Combined HIV‑1/HIV‑2 antibody assay that can replace separate 86701 and 86702 when a single-result panel is used.

    86689 | Antibody; HTLV or HIV antibody, confirmatory test | Used for confirmatory serologic testing when screening immunoassays (including 86702) are reactive or indeterminate.

    87389 | Infectious agent antigen detection; HIV‑1 antigen(s), with HIV‑1 and HIV‑2 antibodies, single result | Combined antigen/antibody assay used in initial HIV screening algorithms; may be used prior to or instead of single antibody testing.

    87390 | Infectious agent antigen detection; HIV‑1 | HIV‑1 p24 antigen detection; used in diagnostic algorithms to identify acute infection and may be ordered alongside antibody testing.

    87391 | Infectious agent antigen detection; HIV‑2 | HIV‑2 antigen detection assays, when available; complements antibody testing for comprehensive evaluation.